Rhugved Health Care Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Rhugved Health Care Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Safalta Ambatkar, Yashwant Ambatkar, and Vivek Ambatkar serve as directors at the Company.
- CIN/LLPIN
U24290MH2021PTC364987
- Company No.
364987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rhugved Health Care Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Safalta Ambatkar  | Director | 30-Jul-2021 | Current |
| Yashwant Ambatkar | Director | 30-Jul-2021 | Current |
| Vivek Ambatkar | Director | 16-Mar-2024 | Current |
Financial Performance of Rhugved Health Care Pharma.
Enhance accessibility to Rhugved Health Care Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rhugved Health Care Pharma?
Unlock access to Rhugved Health Care Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ekvira Suretechcare Pharma Private LimitedActive 3 years 2 monthsSafalta Ambatkar and Yashwant Ambatkar are mutual person
- Gsk Reddy's Suntorent Pharma Private LimitedActive 3 years 8 months
Safalta Ambatkar and Yashwant Ambatkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rhugved Health Care Pharma?
Rhugved Health Care Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhugved Health Care Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhugved Health Care Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
